1. Huang J Y，Rosenwaks Z. Assisted reproductive techniques. Methods Mol Biol，2014，1154; 171-231.

2. Derkx F H，Alberda A T，Zeilmaker G H，et al. High concentrations of immunoreactive renin，prorenin and enzymatically-active renin in human ovarian follicular fluid. Br J Obstet Gynaecol，1987，94（1）; 4-9.

3. Nouri K，Haslinger P，Szabo L，et al. Polymorphisms of VEGF and VEGF receptors are associated with the occurrence of ovarian hyperstimulation syndrome（OHSS）-a retrospective case-control study. J Ovarian Res，2014，7; 54.

4. Aljawoan F Y，Hunt L P，Gordon U D. Prediction of ovarian hyperstimulation syndrome in coasted patients in an IVF/ICSI program. J Hum Reprod Sci，2012，5（1）; 32-36.

5. Chen C D，Wu M Y，Chen H F，et al. Relationships of serum pro-inflammatory cytokines and vascular endothelial growth factor with liver dysfunction in severe ovarian hyperstimulation syndrome. Hum Reprod，2000，15（1）; 66-71.

6. Artini P G，Monti M，Fasciani A，et al. Vascular endothelial growth factor，interleukin-6 and interleukin-2 in serum and follicular fluid of patients with ovarian hyperstimulation syndrome. Eur J Obstet Gynecol Reprod Biol，2002，101（2）; 169-174.

7. Garcia-Velasco J A，Zuniga A，Pacheco A，et al. Coasting acts through downregulation of VEGF gene expression and protein secretion. Hum Reprod，2004，19（7）; 1530-1538.

8. Alama P，Bellver J，Vidal C，et al. GnRH analogues in the prevention of ovarian hyperstimulation syndrome. Int J Endocrinol Metab，2013，11（2）; 107-116.

9. Youssef M A，Al-Inany H G，Evers J L，et al. Intra-venous fluids for the prevention of severe ovarian hyperstimulation syndrome. Cochrane Database Syst Rev，2011（2）; D1302.

10. D'Angelo A，Amso N. Embryo freezing for preventing Ovarian Hyperstimulation Syndrome. Cochrane Database Syst Rev，2002（2）; D2806.

11. Esinler I，Bozdag G，Karakocsokmensuer L. Preventing ovarian hyperstimulation syndrome: cabergoline versus coasting. Arch Gynecol Obstet，2013，288（5）; 1159-1163.

12. El H H，Poulain M，Finet A，et al. Live birth after frozen-thawed oocytes matured in vitro in a PCOS patient: a model for improving implantation rates in IVM cycles and objectively assessing the real potential of development of frozen oocytes matured in vitro. Gynecol Endocrinol，2014，30（6）; 415-418.

13. Son W Y，Yoon S H，Lee S W，et al. Blastocyst development and pregnancies after IVF of mature oocytes retrieved from unstimulated patients with PCOS after in-vivo HCG priming. Hum Reprod，2002，17（1）; 134-136.

14. Tan B K，Mathur R. Management of ovarian hyperstimulation syndrome guidelines. Produced on behalf of the BFS Policy and Practice Committee. Hum Fertil（Camb），2013，16（3）; 160-161.

15. Balasch J，Carmona F，Llach J，et al. Acute prerenal failure and liver dysfunction in a patient with severe ovarian hyperstimulation syndrome. Hum Reprod，1990，5（3）; 348-351.

16. EvbuomwanⅠO，Davison J M，Murdoch A P. Coexistent hemoconcentration and hypoosmolality during superovulation and in severe ovarian hyperstimulation syndrome: a volume homeostasis paradox. Fertil Steril，2000，74（1）; 67-72.

17. Strandivik G F. Hypertonic saline in critical care: a review of the literature and guidelines for use in hypotensive states and raised intracranial pressure. Anaesthesia，2009，64（9）; 990-1003.

18. Grossman L C，Michalakis K G，Browne H，et al. The pathophysiology of ovarian hyperstimulation syndrome: an unrecognized compartment syndrome. Fertil Steril，2010，94（4）; 1392-1398.

19. Bates S M，GreerⅠA，Middeldorp S，et al. VTE，thrombophilia，antithrombotic therapy，and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis，9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest，2012，141（2 Suppl）; 691-736.

20. Oelsner G，Cohen S B，Soriano D，et al. Minimal surgery for the twisted ischaemic adnexa can preserve ovarian function. Hum Reprod，2003，18（12）; 2599-2602.